Global Acne Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Acne Medicine by Type
- 1.3.1 Overview: Global Acne Medicine Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Acne Medicine Consumption Value Market Share by Type in 2023
- 1.3.3 OTC
- 1.3.4 Prescription Medicine
- 1.4 Global Acne Medicine Market by Application
- 1.4.1 Overview: Global Acne Medicine Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Topical
- 1.4.3 Oral
- 1.5 Global Acne Medicine Market Size & Forecast
- 1.6 Global Acne Medicine Market Size and Forecast by Region
- 1.6.1 Global Acne Medicine Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Acne Medicine Market Size by Region, (2019-2030)
- 1.6.3 North America Acne Medicine Market Size and Prospect (2019-2030)
- 1.6.4 Europe Acne Medicine Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Acne Medicine Market Size and Prospect (2019-2030)
- 1.6.6 South America Acne Medicine Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Acne Medicine Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Galderma
- 2.1.1 Galderma Details
- 2.1.2 Galderma Major Business
- 2.1.3 Galderma Acne Medicine Product and Solutions
- 2.1.4 Galderma Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Galderma Recent Developments and Future Plans
- 2.2 Bausch Health
- 2.2.1 Bausch Health Details
- 2.2.2 Bausch Health Major Business
- 2.2.3 Bausch Health Acne Medicine Product and Solutions
- 2.2.4 Bausch Health Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Bausch Health Recent Developments and Future Plans
- 2.3 Teva
- 2.3.1 Teva Details
- 2.3.2 Teva Major Business
- 2.3.3 Teva Acne Medicine Product and Solutions
- 2.3.4 Teva Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Teva Recent Developments and Future Plans
- 2.4 GlaxoSmithKline
- 2.4.1 GlaxoSmithKline Details
- 2.4.2 GlaxoSmithKline Major Business
- 2.4.3 GlaxoSmithKline Acne Medicine Product and Solutions
- 2.4.4 GlaxoSmithKline Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 GlaxoSmithKline Recent Developments and Future Plans
- 2.5 Mylan
- 2.5.1 Mylan Details
- 2.5.2 Mylan Major Business
- 2.5.3 Mylan Acne Medicine Product and Solutions
- 2.5.4 Mylan Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Mylan Recent Developments and Future Plans
- 2.6 Almirall
- 2.6.1 Almirall Details
- 2.6.2 Almirall Major Business
- 2.6.3 Almirall Acne Medicine Product and Solutions
- 2.6.4 Almirall Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Almirall Recent Developments and Future Plans
- 2.7 Sun Pharma
- 2.7.1 Sun Pharma Details
- 2.7.2 Sun Pharma Major Business
- 2.7.3 Sun Pharma Acne Medicine Product and Solutions
- 2.7.4 Sun Pharma Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Sun Pharma Recent Developments and Future Plans
- 2.8 Mayne Pharma
- 2.8.1 Mayne Pharma Details
- 2.8.2 Mayne Pharma Major Business
- 2.8.3 Mayne Pharma Acne Medicine Product and Solutions
- 2.8.4 Mayne Pharma Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Mayne Pharma Recent Developments and Future Plans
- 2.9 Lion
- 2.9.1 Lion Details
- 2.9.2 Lion Major Business
- 2.9.3 Lion Acne Medicine Product and Solutions
- 2.9.4 Lion Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Lion Recent Developments and Future Plans
- 2.10 HUAPONT
- 2.10.1 HUAPONT Details
- 2.10.2 HUAPONT Major Business
- 2.10.3 HUAPONT Acne Medicine Product and Solutions
- 2.10.4 HUAPONT Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 HUAPONT Recent Developments and Future Plans
- 2.11 Sine Pharma
- 2.11.1 Sine Pharma Details
- 2.11.2 Sine Pharma Major Business
- 2.11.3 Sine Pharma Acne Medicine Product and Solutions
- 2.11.4 Sine Pharma Acne Medicine Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Sine Pharma Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Acne Medicine Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Acne Medicine by Company Revenue
- 3.2.2 Top 3 Acne Medicine Players Market Share in 2023
- 3.2.3 Top 6 Acne Medicine Players Market Share in 2023
- 3.3 Acne Medicine Market: Overall Company Footprint Analysis
- 3.3.1 Acne Medicine Market: Region Footprint
- 3.3.2 Acne Medicine Market: Company Product Type Footprint
- 3.3.3 Acne Medicine Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Acne Medicine Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Acne Medicine Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Acne Medicine Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Acne Medicine Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Acne Medicine Consumption Value by Type (2019-2030)
- 6.2 North America Acne Medicine Market Size by Application (2019-2030)
- 6.3 North America Acne Medicine Market Size by Country
- 6.3.1 North America Acne Medicine Consumption Value by Country (2019-2030)
- 6.3.2 United States Acne Medicine Market Size and Forecast (2019-2030)
- 6.3.3 Canada Acne Medicine Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Acne Medicine Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Acne Medicine Consumption Value by Type (2019-2030)
- 7.2 Europe Acne Medicine Consumption Value by Application (2019-2030)
- 7.3 Europe Acne Medicine Market Size by Country
- 7.3.1 Europe Acne Medicine Consumption Value by Country (2019-2030)
- 7.3.2 Germany Acne Medicine Market Size and Forecast (2019-2030)
- 7.3.3 France Acne Medicine Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Acne Medicine Market Size and Forecast (2019-2030)
- 7.3.5 Russia Acne Medicine Market Size and Forecast (2019-2030)
- 7.3.6 Italy Acne Medicine Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Acne Medicine Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Acne Medicine Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Acne Medicine Market Size by Region
- 8.3.1 Asia-Pacific Acne Medicine Consumption Value by Region (2019-2030)
- 8.3.2 China Acne Medicine Market Size and Forecast (2019-2030)
- 8.3.3 Japan Acne Medicine Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Acne Medicine Market Size and Forecast (2019-2030)
- 8.3.5 India Acne Medicine Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Acne Medicine Market Size and Forecast (2019-2030)
- 8.3.7 Australia Acne Medicine Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Acne Medicine Consumption Value by Type (2019-2030)
- 9.2 South America Acne Medicine Consumption Value by Application (2019-2030)
- 9.3 South America Acne Medicine Market Size by Country
- 9.3.1 South America Acne Medicine Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Acne Medicine Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Acne Medicine Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Acne Medicine Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Acne Medicine Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Acne Medicine Market Size by Country
- 10.3.1 Middle East & Africa Acne Medicine Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Acne Medicine Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Acne Medicine Market Size and Forecast (2019-2030)
- 10.3.4 UAE Acne Medicine Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Acne Medicine Market Drivers
- 11.2 Acne Medicine Market Restraints
- 11.3 Acne Medicine Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Acne Medicine Industry Chain
- 12.2 Acne Medicine Upstream Analysis
- 12.3 Acne Medicine Midstream Analysis
- 12.4 Acne Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
According to our (Global Info Research) latest study, the global Acne Medicine market size was valued at US$ 3592 million in 2023 and is forecast to a readjusted size of USD 4512 million by 2030 with a CAGR of 3.3% during review period.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
This report is a detailed and comprehensive analysis for global Acne Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Acne Medicine market size and forecasts, in consumption value ($ Million), 2019-2030
Global Acne Medicine market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Acne Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Acne Medicine market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Acne Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Acne Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma, Lion, HUAPONT, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Acne Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Acne Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
OTC
Prescription Medicine
Market segment by Application
Topical
Oral
Market segment by players, this report covers
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Acne Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Acne Medicine, with revenue, gross margin, and global market share of Acne Medicine from 2019 to 2024.
Chapter 3, the Acne Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Acne Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Acne Medicine.
Chapter 13, to describe Acne Medicine research findings and conclusion.